Development of Highly Sensitive Molecular Blocks at Cancer Microenvironment for Rapid Cancer Cell Death

Marie Piantino1, Masahiko Nakamoto1, Michiya Matsusaki1

  • 1Division of Applied Chemistry, Graduate School of Engineering, Osaka University, Suita, Osaka 565-0871 Japan.

Insights

Optimized molecular blocks (MBs) enhance cancer drug delivery by improving tumor accumulation and targeting. This approach reduces off-target effects and increases cancer cell death through pH-responsive aggregation.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapy

Background:

  • Improving drug delivery systems (DDS) for cancer therapy remains a significant challenge.
  • Nanocarriers face issues like rapid blood clearance and tumor stromal tissue blockage, hindering drug transport.
  • Existing methods require multiple steps for intracellular drug delivery.

Purpose of the Study:

  • To optimize molecular blocks (MBs) for enhanced cancer microenvironment targeting and drug delivery.
  • To improve the hydrophilic-hydrophobic balance of MBs to prevent off-target accumulation.
  • To increase MB sensitivity to the acidic tumor microenvironment for efficient cancer cell killing.

Main Methods:

  • Modification of MBs using copper-free click reaction with propiolic acid to tune hydrophobicity.
  • Evaluation of MB performance in terms of circulation, tumor accumulation, and cancer cell targeting.
  • Assessment of pH-driven self-aggregation and cell membrane disruption capabilities.

Main Results:

  • Optimized MBs demonstrated reduced off-target accumulation in bloodstream.
  • Enhanced sensitivity of MBs to weak acidic conditions characteristic of the tumor microenvironment.
  • Successful pH-driven self-aggregation and disruption of cancer cell membranes.

Conclusions:

  • Optimized MBs show improved tumor accumulation and selectivity.
  • The modified MBs offer a promising strategy for enhanced cancer cell targeting and therapy.
  • This approach addresses key limitations in current nanocarrier-based drug delivery systems.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K